Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03553836
Brief Title: Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

First Submitted : June 1, 2018
First Submitted that Met QC Criteria : June 1, 2018
First Posted : June 12, 2018

Last Update Submitted that Met QC Criteria : November 10, 2020
Last Update Posted : November 12, 2020